CASSANDRI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 342
EU - Europa 155
AS - Asia 116
Continente sconosciuto - Info sul continente non disponibili 1
Totale 614
Nazione #
US - Stati Uniti d'America 342
SG - Singapore 105
IT - Italia 84
IE - Irlanda 18
RU - Federazione Russa 11
GB - Regno Unito 10
FR - Francia 9
DE - Germania 7
SE - Svezia 5
CN - Cina 4
FI - Finlandia 3
IN - India 2
IR - Iran 2
JP - Giappone 2
LV - Lettonia 2
PL - Polonia 2
A1 - Anonimo 1
CH - Svizzera 1
EE - Estonia 1
GR - Grecia 1
RS - Serbia 1
TW - Taiwan 1
Totale 614
Città #
Singapore 98
Wilmington 49
Houston 46
New York 29
Rome 29
Santa Clara 20
Dublin 17
Ashburn 16
Chandler 13
Fairfield 13
Moscow 8
Center 7
Woodbridge 7
Medford 6
Ayn 5
London 5
Engelhard 4
Foggia 4
Garden City 4
Milan 4
Mülheim 4
Beijing 3
Cambridge 3
Council Bluffs 3
Lappeenranta 3
Lawrence 3
Palermo 3
Seattle 3
Ardea 2
Bitonto 2
Colorado Springs 2
Columbus 2
Guilford 2
Osaka 2
Paris 2
Pune 2
Rasht 2
Riga 2
Roseto degli Abruzzi 2
St. George 2
Warsaw 2
Belgrade 1
Boardman 1
Borås 1
Chiswick 1
Cork 1
Falls Church 1
Gunzenhausen 1
Kilburn 1
Las Vegas 1
Los Angeles 1
Magenta 1
Mompeo 1
Mountain View 1
Nagold 1
Norwalk 1
Novodvinsk 1
Piraeus 1
Pittsburgh 1
Prescot 1
Redwood City 1
Rockville 1
Santa Maria a Vico 1
Shenzhen 1
Stockholm 1
Taipei 1
Tallinn 1
Tempe 1
Trieste 1
Washington 1
Totale 464
Nome #
Zinc-finger proteins in health and disease 169
ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes 67
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 42
Radioresistance in rhabdomyosarcomas: much more than a question of dose 40
The ZNF750-RAC1 axis as potential prognostic factor for breast cancer 36
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas 31
ZFP750 affects the cutaneous barrier through regulating lipid metabolism 29
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 28
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 27
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 23
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 22
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma 19
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 19
FAK Signaling in Rhabdomyosarcoma 18
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 18
New Insights on the Nuclear Functions and Targeting of FAK in Cancer 18
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression 17
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 17
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma 17
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 13
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor 10
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells 9
Totale 689
Categoria #
all - tutte 5.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 0 0 20 10 10 7
2020/202175 10 7 9 7 10 10 7 10 3 2 0 0
2021/202250 0 3 2 13 1 0 2 7 6 5 1 10
2022/2023180 5 3 2 2 2 10 77 14 11 21 23 10
2023/2024125 11 2 6 6 10 33 13 7 15 7 4 11
2024/2025212 19 122 71 0 0 0 0 0 0 0 0 0
Totale 689